Ali Iranmanesh

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Transdermal Testosterone Gel Improves Sexual Function, Mood, Muscle Strength, and Body Composition Parameters in Hypogonadal Men1

Christina Wang, Ronald S. Swerdloff, Ali Iranmanesh et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 847 citations · Full text

Age and Relative Adiposity Are Specific Negative Determinants of the Frequency and Amplitude of Growth Hormone (GH) Secretory Bursts and the Half-Life of Endogenous GH in Healthy Men*

Ali Iranmanesh, GERMAN LIZARRALDE, Johannes D. Veldhuis · The Journal of Clinical Endocrinology & Metabolism · 1991 · 675 citations

Aging, Human Growth, Neuroendocrinology +17

Long-Term Testosterone Gel (AndroGel) Treatment Maintains Beneficial Effects on Sexual Function and Mood, Lean and Fat Mass, and Bone Mineral Density in Hypogonadal Men

Christina Wang, Glenn R. Cunningham, Adrian S. Dobs et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 649 citations · Full text

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10